Insider Transactions in Q3 2024 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 19
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,651
-2.45%
|
$5,651
$1.28 P/Share
|
|
Aug 19
2024
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
6,866
-2.66%
|
$6,866
$1.28 P/Share
|
|
Aug 19
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
14,881
-1.72%
|
$14,881
$1.28 P/Share
|